Nota Bene Episode 20: The Evolving Nature of the U.S. Healthcare Industry with David Garcia
The healthcare industry in the U.S. is different than the healthcare systems of just about every other country in the developed world. As the industry continues to evolve with the injection of private funds and the changing roles of physicians, we’re exploring how the changes in this sector impact antitrust laws. Furthermore, we’re highlighting what business leaders should know about the changes in this industry.
Joining host Michael Cohen to share his deep insight on competition laws in the healthcare industry is David Garcia. David is a partner in Sheppard Mullin’s Century City office, where he is also the Office Managing Partner. He is a litigator with a broad background in complex civil litigation for major U.S. companies, including extensive class action and multidistrict litigation experience. His practice focuses principally on antitrust litigation and counseling with particular emphasis on the entertainment industry, healthcare litigation and mergers and the intersection between antitrust and intellectual property in litigation and joint ventures.
What We Discuss in This Episode:
What does antitrust have to do with healthcare?
Why is it that mergers and acquisitions in this industry are astoundingly high?
Where are many of the mergers and acquisitions in healthcare occurring?
How has private equity and venture capital money transformed the healthcare industry?
Categorically, who are the major players in this sector?
What is the difference between in-patient and out-patient care?
How what it means to be a doctor in the U.S. has changed fundamentally
How has the aging population driven the increase of government expenditures?
What is “managed care” and how does it affect antitrust laws?
Should concentrated markets be avoided?
The nature of horizontal and vertical consolidation in the healthcare industry
David's article - Amex Ruling May Have Big Impact on Health Insurance